Open access · CC-BY
via OpenAlex
The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)
Frank J. Wolters, Qiong Yang, Mary L. Biggs, Jóhanna Jakobsdóttir, Shuo Li, Daniel S. Evans, Joshua C. Bis, Tamara B. Harris, Ramachandran Srini Vasan, Nuno R. Zilhäo, Mohsen Ghanbari, M. Arfan Ikram, Lenore J. Launer, Bruce M. Psaty, Gregory J. Tranah
PLoS ONE · 2019 · ▲ 75 citations
Abstract
BACKGROUND: Apolipoprotein E is a glycoprotein best known as a mediator and regulator of lipid transport and uptake. The APOE-ε4 allele has long been associated with increased risks of Alzheimer's disease and mortality, but the effect of the less prevalent APOE-ε2 allele on diseases in the elderly and survival remains elusive. METHODS: We aggregated data of 38,537 individuals of European ancestry (mean age 65.5 years; 55.6% women) from six population-based cohort studies (Rotterdam Study, AGES-Reykjavik Study, Cardiovascular Health Study, Health-ABC Study, and the family-based Framingham Heart Study and Long Life Family Study) to determine the association of APOE, and in particular APOE-ε2, with survival in the population. RESULTS: During a mean follow-up of 11.7 years, 17,021 individuals died. Compared with homozygous APOE-ε3 carriers, APOE-ε2 carriers were at lower risk of death (hazard ratio,95% confidence interval: 0.94,0.90-0.99; P = 1.1*10-2), whereas APOE-ε4 carriers were at increased risk of death (HR 1.17,1.12-1.21; P = 2.8*10-16). APOE was associated with mortality risk in a dose-dependent manner, with risk estimates lowest for homozygous APOE-ε2 (HR 0.89,0.74-1.08), and highest for homozygous APOE-ε4 (HR 1.52,1.37-1.70). After censoring for dementia, effect estimates remained similar for APOE-ε2 (HR 0.95,0.90-1.01), but attenuated for APOE-ε4 (HR 1.07,1.01-1.12). Results were broadly similar across cohorts, and did not differ by age or sex. APOE genotype was associated with baseline lipid fractions (e.g. mean difference(95%CI) in LDL(mg/dL) for ε2 versus ε33: -17.1(-18.1-16.0), and ε4 versus ε33: +5.7(4.8;6.5)), but the association between APOE and mortality was unaltered after adjustment for baseline LDL or cardiovascular disease. Given the European ancestry of the study population, results may not apply to other ethnicities. CONCLUSION: Compared with APOE-ε3, APOE-ε2 is associated with prolonged survival, whereas mortality risk is increased for APOE-ε4 carriers. Further collaborative efforts are needed to unravel the role of APOE and in particular APOE-ε2 in health and disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0219668
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Wolters, F.J., Yang, Q., Biggs, M.L., Jakobsdóttir, J., Li, S., Evans, D.S., Bis, J.C., Harris, T.B., Vasan, R.S., Zilhäo, N.R., Ghanbari, M., Ikram, M.A., Launer, L.J., Psaty, B.M., Tranah, G.J., Kulminski, A.M., Gudnason, V.G., Seshadri, S.S., & investigators, F.T.E. (2019). The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE). <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0219668
Vancouver
Wolters FJ, Yang Q, Biggs ML, Jakobsdóttir J, Li S, Evans DS, et al. The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE). PLoS ONE. 2019. doi:10.1371/journal.pone.0219668.
BibTeX
@article{frank2019Theimp,
title = {The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)},
author = {Frank J. Wolters and Qiong Yang and Mary L. Biggs and Jóhanna Jakobsdóttir and Shuo Li and Daniel S. Evans and Joshua C. Bis and Tamara B. Harris and Ramachandran Srini Vasan and Nuno R. Zilhäo and Mohsen Ghanbari and M. Arfan Ikram and Lenore J. Launer and Bruce M. Psaty and Gregory J. Tranah and Alexander M. Kulminski and Vilmundur G. Gudnason and Sudha S. Seshadri and for the E2-CHARGE investigators},
journal = {PLoS ONE},
year = {2019},
doi = {10.1371/journal.pone.0219668},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Geriatrics 2011
Open access · CC-BY
Analysis of frailty and survival from late middle age in the Beijing Longitudinal Study of Aging
Journal of Psychiatry and Neuroscience 2018
Open access · OA
Arterial stiffness is associated with depression in middle-aged men — the Maastricht Study
National Institute on Aging (NIA) 2012
Open access · US-GOV
Age-Associated Changes in Regional Adiposity and Novel Cardiovascular Risk Factors
Journal of Alzheimer s Disease 2023
Open access · CC-BY
Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype
Journal of Atherosclerosis and Thrombosis 2023
Open access · CC-BY
Cardiovascular Risk Age Reflects Arterial Status: Middle-Aged People Showed Equivalent Arterial Stiffness to Older People in the Same Risk Category
American Journal of Epidemiology 1995
Citation only